Search results
Results from the WOW.Com Content Network
Dutasteride is sometimes used as a component of hormone therapy for transgender women in combination with an estrogen and/or another antiandrogen such as spironolactone. [7] It may be useful for preventing and treating scalp hair loss and can also be used as a general antiandrogen for in those who have issues tolerating spironolactone, though as a α-reductase inhibitor it has limited effects ...
Finasteride is most effective on the crown but can reduce hair loss in all areas of the scalp. [27] [28] Finasteride has also been tested for pattern hair loss in women; however, the results were no better than placebo. [29] Finasteride is less effective in the treatment of scalp hair loss than dutasteride. [30] [31]
Finasteride. Finasteride (generic for Propecia) is a prescription medication for treating male pattern baldness. It works by inhibiting the 5-alpha-reductase enzyme that converts testosterone into ...
Let’s talk 5mg finasteride vs 1mg—two different doses, one powerful hair loss treatment. Finasteride is the active ingredient in Propecia®, an oral medication that’s clinically-proven to ...
There were no differences in the rates of depression, self-harm, and suicide between finasteride and dutasteride, suggesting that the specific 5-ARI used does not influence the risks. [33] [21] [34] The absolute risks of self-harm and depression with 5-ARIs remain low (0.14% and 2.0%, respectively). [35]
Post-finasteride syndrome or PFS refers to a range of intimacy, physical, and mental health symptoms associated with the use of finasteride as a treatment for hair loss and benign prostatic ...
Two azasteroids, finasteride and dutasteride, are used clinically as 5α-reductase inhibitors. [1] [2] [3] Finasteride and dutasteride, two azasteroid pharmaceutical drugs. The nitrogen atoms in each ring system are highlighted in red. Some of the 6-azasteroids may prove to be useful drugs, but have yet to reach the pharmaceutical market. [4] [5]
The most recent development in this line of research came in 2019 when researchers found no increase in the number of prostate cancer deaths between the group that used finasteride and a control ...